Federal Court Upholds West Virginia Law that Reins in “Bad Drug” Ads
In a victory for patient protections, a federal appellate court upheld a West Virginia law designed to put guardrails on unscrupulous “bad drug” advertising.
One-sided Ads Put Patients’ Health at Risk
It’s Time to Rein In Dangerous “Bad Drug” Ads
By Frank Lavernia, MD
As one of the many physicians who has seen patients harmed by misleading television advertisements, I urge policymakers to make this the year they rein in “bad drug” ads.
The Dangers of "Bad Drug" Ads
An Advanced Practice Registered Nurse's Point of View
An Interview with Chloe Villavaso, MN, APRN
Chloe Villavaso, MN, APRN, is an instructor of medicine at Tulane University School of Medicine in New Orleans, Louisiana.
Let’s Talk about “Bad Drug” Ads
A Physician’s Point of View
Dr. Lavernia, a diabetes specialist from Coconut Creek, Florida, discusses the harmful effects of “bad drug” ads.
General "Bad Drug" Ad Social Graphics
Lawmakers & Regulators Tackle “Bad Drug” Ads
“Bad drug” ads often target seniors with misinformation about prescription medications, with their scare tactics costing viewers their health – even their lives. Now the Federal Trade Commission is highlighting the importance of protecting consumers from questionable advertising practices.